Indications and uses
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
place 1 tablet on tongue; tablet disintegrates, with or without water adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
Loratadine, USP 10 mg
Antihistamine
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
If you have ever had an allergic reaction to this product or any of its ingredients.
Liver or kidney disease. Your doctor should determine if you need a different dose.
Do not take more than directed. Taking more than directed may cause drowsiness.
An allergic reaction to this product occurs. Seek medical help right away.
Ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
| adults and children 6 years and over | 1 tablet daily; not more than 1 tablet in 24 hours |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
Aspartame, croscarmellose sodium, magnesium stearate, mannitol, mint flavor, sodium stearyl fumarate, strawberry cream flavor, tutti-frutti flavor
Call 1-800-406-7984
SHOPKO®
†Compare to the Active Ingredient of Claritin®RediTabs®
Original Prescription Strength
Allergy Relief
Loratadine Orally Disintegrating Tablets, USP 10 mg
Antihistamine
Non-Drowsy*
Indoor & Outdoor Allergies
24 Hour Allergy Relief
For Adults and Children six years and older!
Relief of: Sneezing, Runny Nose, Itchy/Watery Eyes, Itchy Throat or Nose
• No Water Needed • Melts in Your Mouth
*When taken as directed. See Drug Facts Panel.
Manufactured by: Ohm Laboratories Inc.
5093689/R0512

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 37012-527-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0ba0-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 37012-527-31 | Loratadine ODT | 30 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 30 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LORATADINE | ACTIVE INGREDIENT | 7AJO3BO7QN | 1 | |
| LORATADINE | ACTIVE MOIETY | 7AJO3BO7QN | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | 1 | |
| SODIUM STEARYL FUMARATE | INACTIVE INGREDIENT | 7CV7WJK4UI | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 37012-527 | 37012-527-31 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LORATADINE | 7AJO3BO7QN | ACTIB |
| ASPARTAME | Z0H242BBR1 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MANNITOL | 3OWL53L36A | IACT |
| SODIUM STEARYL FUMARATE | 7CV7WJK4UI | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ASPARTAME | ASPARTAME | Z0H242BBR1 | SOLUTION / ORAL | 40 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | SUSPENSION / ORAL | 150 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | GEL / OPHTHALMIC | 25 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | TABLET, EXTENDED RELEASE / ORAL | 42 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | POWDER, FOR SUSPENSION / ORAL | 7093 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | TABLET, ORALLY DISINTEGRATING / ORAL | 153 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 105 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SOLUTION, GEL FORMING / DROPS / OPHTHALMIC | 4 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | GRANULE, FOR SUSPENSION / ORAL | 6000 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | TABLET, FOR SUSPENSION / ORAL | 15 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | GRANULE / ORAL | 77 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 980.4 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / BUCCAL | 17.5 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | CAPSULE / ORAL | 180 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CONCENTRATE / INTRAVENOUS | 220 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | TABLET, FILM COATED / ORAL | 20 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET, FILM COATED / ORAL | 2309 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | LOZENGE / ORAL | 136 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | WAFER / ORAL | 642 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | SYRUP / ORAL | 0.63 mg/5ml | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | GRANULE, FOR SOLUTION / ORAL | 18.2 mg/120ml | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | POWDER, FOR SOLUTION / ORAL | 233 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1568 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, SOLUTION / INTRAVENOUS | 15400 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 4.35 %w/w | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TROCHE / ORAL | 315 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | TABLET, CHEWABLE / ORAL | 28 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | CAPSULE, DELAYED RELEASE / ORAL | 8.4 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 658 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CAPSULE / ORAL | 1562 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | TABLET / ORAL | 87 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, EXTENDED RELEASE / ORAL | 392 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | GRANULE, FOR SUSPENSION / ORAL | 420 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | PELLET / ORAL | 43 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SOLUTION / PARENTERAL | 200 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET, DELAYED RELEASE / ORAL | 639 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | GUM, CHEWING / BUCCAL | 891 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | TABLET, FILM COATED / ORAL | 98 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | TABLET / ORAL | 153 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | DROPS / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SOLUTION / ORAL | 869 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET / BUCCAL | 360 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | LOZENGE / ORAL | 20546 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION / ORAL | 64 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | LOZENGE / ORAL | 125 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SOLUTION / SUBCUTANEOUS | 4.54 %w/v | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | FILM, EXTENDED RELEASE / BUCCAL | 1 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TROCHE / ORAL | 50 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / TOPICAL | 104 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | GRANULE, FOR SUSPENSION / ORAL | 14 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | CAPSULE, EXTENDED RELEASE / ORAL | 3 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SUSPENSION, EXTENDED RELEASE / ORAL | 2464.6 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077153-001 | LORATADINE REDIDOSE | LORATADINE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A077153-001 | LORATADINE REDIDOSE | 10MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2007-04-11 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 03adedd8-1cda-4e10-a2a2-5680a260809e | 8d7cedb3-6edc-4e9d-9f18-08158d176fdd | 2013-03-21 | Warnings | 03adedd8-1cda-4e10-a2a2-5680a260809e 8d7cedb3-6edc-4e9d-9f18-08158d176fdd |
Adverse event summaries are temporarily unavailable. Other product information remains available.